Lancet (UK), 378(9809), 2081-2087. Elsevier Ltd. Lancet, 378(9809), 2081-2087 Lancet Burn, J, Gerdes, A-M, Macrae, F, Mecklin, J-P, Moeslein, G, Olschwang, S, Eccles, D, Evans, D G, Maher, E R, Bertario, L, Bisgaard, M-L, Dunlop, M G, Ho, J W C, Hodgson, S V, Lindblom, A, Lubinski, J, Morrison, P J, Murday, V, Ramesar, R, Side, L, Scott, R J, Thomas, H J W, Vasen, H F, Barker, G, Crawford, G, Elliott, F, Movahedi, M, Pylvanainen, K, Wijnen, J T, Fodde, R, Lynch, H T & Mathers, J C & Bishop, D T 2011, ' Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer : an analysis from the CAPP2 randomised controlled trial ', The Lancet, vol. 378, no. 9809, pp. 2081-7 . https://doi.org/10.1016/S0140-6736(11)61049-0